Suzanne Trudel
0000-0001-7952-6352
4 papers found
Refreshing results…
Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial
Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression
Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression
Missing publications? Search for publications with a matching author name.